Cargando…
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database
OBJECTIVES: Emerging treatments for relapsed or refractory multiple myeloma (rrMM) have led to increasing options for many patients. This study aimed to assess changes in utilization of these options in Germany with a focus on modern triplet regimens including new agents, such as carfilzomib, ixazom...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894176/ https://www.ncbi.nlm.nih.gov/pubmed/32989806 http://dx.doi.org/10.1111/ejh.13523 |